Market By Test Types, Technology, Display Device, End-users And Geography | Forecast 2019-2027
According to Triton, the global cardiovascular ultrasound system market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 5.31%. The market was assessed to be worth $1431.05 million in the year 2018 and is predicted to generate a revenue of approximately $2284.96 million by the year 2027.
Cardiovascular diseases involve the sickness of heart or blood vessels. Cardiovascular diseases comprise of coronary artery diseases, such as myocardial infarction (also known as a heart attack) and angina. Other CVDs include stroke, rheumatic heart, heart failure, hypertensive heart disease, disease, heart arrhythmia, cardiomyopathy, congenital heart disease, venous thrombosis carditis, valvar heart disease, thromboembolic disease, aortic aneurysms and peripheral artery disease.
We provide additional customization based on your specific requirements. Request For Customization
The primary procedures differ depending on the disease. For example; atherosclerosis is a condition, which develops due to building up of a substance called plaque in the walls of the arteries. This condition narrows the arteries, making it harder for blood to flow through. If a blood clot forms, then it can stop the flow of the blood, resulting in a heart attack or stroke.
Cardiovascular diseases can be treated or prevented through various medications. The drugs used for the treatment of cardiovascular diseases either enhance the pumping capacity of the heart or increase the supply of oxygen to the heart. The major drugs prescribed for the treatment of cardiovascular diseases consist of Heparin, Coumadin (warfarin), Zebeta (bisoprolol), Sectral (acebutolol), Lopressor, Toprol XL (metoprolol), Lotrel (amlodipine), Norvasc, Sular (nisoldipine) and Vascor (bepridil).
For addressing the unmet needs regarding the development of drugs for cardiovascular diseases, researchers are focusing on the development of cell-based therapies. For example, Dabigatran (Pradaxa; Boehringer Ingelheim, USA) is a direct thrombin inhibitor and Darapladib (GlaxoSmithKline Inc., UK), is a lipoprotein-associated phospholipase A2 inhibitor. In addition, apart from ingestion of drugs through conventional mode, i.e., oral and parenteral, various developed devices are also being introduced in the market that enables drug delivery by mode of balloons, drug-eluting stents and drug-eluting vascular grafts.
The Triton report on the cardiovascular ultrasound system market discusses in detail about the key insights, value chain outlook, market outlook, key buying outlook, Porter’s five force analysis and the regulatory outlook.
The key drivers like technology advancement, rising healthcare expenditure, rise in the usage of minimally invasive procedures and surge in cardiovascular diseases are escalating the growth of the market across the globe. Factors such as the increasing adoption of alternative technologies, weak reimbursement policy and the high cost of surgeries are affecting the market growth negatively.
To get detailed insights on segments, Request Free Sample Report
The prime factors, such as rapidly rising demand for mobile-based ultrasonic devices and upsurge in the research & development are anticipated to leverage the market growth between the projected years. However, challenges like interventional cardiology device complications, stringent government regulations and high costs associated with coronary stents and cardiac catheter-based treatments are hindering the development of the market significantly.
The key geographies that have been covered in the cardiovascular ultrasound system market are:
• North America cardiovascular ultrasound system: the United States and Canada
• Europe cardiovascular ultrasound system: the United Kingdom, Germany, France, Italy, Benelux, Russia and Rest of Europe
• Asia Pacific cardiovascular ultrasound system: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Latin America cardiovascular ultrasound system: Brazil, Mexico and Argentina
• The Middle East and Africa cardiovascular ultrasound system: Israel, Iran, Saudi Arabia, South Africa and Rest of the Middle East & Africa
The cardiovascular ultrasound system market segmentation:
• By test types:
o Transthoracic echocardiogram
o Transesophageal echocardiogram
o Stress echocardiogram
o Other echocardiograms
• By technology:
o 2D ultrasound
o 3D & 4D ultrasound
o Doppler imaging
• By display device:
o Color display
o Black and white display
• By end-user:
o Hospitals and cardiology centres
o Home and ambulatory care settings
o Other end-users
The top companies that have been studied in the cardiovascular ultrasound system market are Samsung Electronics Co., Ltd., Unetixs Vascular, Inc. (acquired by Opto Circuits), AtriCure, Inc., Esaote S.p.A., Boston Scientific Corporation, GE Healthcare, Inc., Hitachi Medical Corporation, Toshiba Medical Systems Corporation (acquired by Canon, Inc.), Fujifilm Holdings Corporation, CHISON Medical Imaging Co., Ltd., Mindray Medical International Limited, Philips Healthcare, Abbott Vascular, Inc., Stryker Corporation and Ultrasound Technologies Ltd.
The strategic analysis for each of these companies in the cardiovascular ultrasound system market has been covered in detail. The company market share helps to dive into the information about the key market players and their hold on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Test Types, Technolo ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT1.
GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES OUTLOOK
2.2.1.
INTENSITY OF COMPETITIVE RIVALRY
2.2.2.
THREATS OF NEW ENTRANTS
2.2.3.
THREAT OF SUBSTITUTE PRODUCTS
2.2.4.
BARGAINING POWER OF BUYER
2.2.5.
BARGAINING POWER OF SUPPLIER
2.3. VENDOR SCORECARD
2.4. KEY INSIGHTS
2.5. VALUE CHAIN OUTLOOK
2.6. MARKET OUTLOOK
2.7. KEY BUYING OUTLOOK
2.8. REGULATORY OUTLOOK
2.9. MARKET DRIVERS
2.9.1.
ADVANCEMENT IN TECHNOLOGY
2.9.2.
RISING HEALTHCARE EXPENDITURE
2.9.3.
RISE IN THE USAGE OF MINIMALLY INVASIVE PROCEDURES
2.9.4.
SURGE IN CARDIOVASCULAR DISEASES
2.10.
MARKET RESTRAINTS
2.10.1.
INCREASING ADOPTION OF ALTERNATIVE TECHNOLOGIES
2.10.2.
WEAK REIMBURSEMENT POLICY
2.10.3.
HIGH COST OF SURGERIES
2.11.
MARKET OPPORTUNITIES
2.11.1.
RAPID INCREASE IN THE DEMAND OF MOBILE-BASED ULTRASOUND DEVICES
2.11.2.
UPSURGE IN RESEARCH AND DEVELOPMENT
2.12.
MARKET CHALLENGES
2.12.1.
INTERVENTIONAL CARDIOLOGY DEVICES COMPLICATIONS
2.12.2.
STRINGENT GOVERNMENT REGULATIONS
2.12.3.
HIGH COSTS ASSOCIATED WITH CORONARY STENTS AND CARDIAC CATHETER-BASED
TREATMENTS
3.
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET OUTLOOK - BY TEST TYPES
3.1. TRANSTHORACIC ECHOCARDIOGRAM
3.2. TRANSESOPHAGEAL ECHOCARDIOGRAM
3.3. STRESS ECHOCARDIOGRAM
3.4. OTHER ECHOCARDIOGRAM
4.
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET OUTLOOK - BY TECHNOLOGY
4.1. 2D ULTRASOUND
4.2. 3D & 4D ULTRASOUND
4.3. DOPPLER IMAGING
5.
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET OUTLOOK - BY DISPLAY DEVICE
5.1. COLOR DISPLAY
5.2. BLACK & WHITE DISPLAY
6.
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET OUTLOOK - BY END-USER
6.1. HOSPITAL & CARDIOLOGY CENTERS
6.2. HOME & AMBULATORY CARE SETTINGS
6.3. OTHER END-USERS
7.
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET - REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1.
MARKET BY TEST TYPES
7.1.2.
MARKET BY TECHNOLOGIES
7.1.3.
MARKET BY DISPLAY DEVICES
7.1.4.
MARKET BY END-USER
7.1.5.
COUNTRY ANALYSIS
7.1.5.1.
THE UNITED STATES
7.1.5.2.
CANADA
7.2. EUROPE
7.2.1.
MARKET BY TEST TYPES
7.2.2.
MARKET BY TECHNOLOGIES
7.2.3.
MARKET BY DISPLAY DEVICES
7.2.4.
MARKET BY END-USER
7.2.5.
COUNTRY ANALYSIS
7.2.5.1.
GERMANY
7.2.5.2.
THE UNITED KINGDOM
7.2.5.3.
FRANCE
7.2.5.4.
RUSSIA
7.2.5.5.
BENELUX
7.2.5.6.
ITALY
7.2.5.7.
REST OF EUROPE
7.3. ASIA-PACIFIC
7.3.1.
MARKET BY TEST TYPES
7.3.2.
MARKET BY TECHNOLOGIES
7.3.3.
MARKET BY DISPLAY DEVICES
7.3.4.
MARKET BY END-USER
7.3.5.
COUNTRY ANALYSIS
7.3.5.1.
JAPAN
7.3.5.2.
CHINA
7.3.5.3.
SOUTH KOREA
7.3.5.4.
INDIA
7.3.5.5.
AUSTRALIA & NEW ZEALAND
7.3.5.6.
ASEAN COUNTRIES
7.3.5.7.
REST OF ASIA-PACIFIC
7.4. LATIN AMERICA
7.4.1.
MARKET BY TEST TYPES
7.4.2.
MARKET BY TECHNOLOGIES
7.4.3.
MARKET BY DISPLAY DEVICES
7.4.4.
MARKET BY END-USER
7.4.5.
COUNTRY ANALYSIS
7.4.5.1.
MEXICO
7.4.5.2.
BRAZIL
7.4.5.3.
ARGENTINA
7.5. MIDDLE EAST AND AFRICA
7.5.1.
MARKET BY TEST TYPES
7.5.2.
MARKET BY TECHNOLOGIES
7.5.3.
MARKET BY DISPLAY DEVICES
7.5.4.
MARKET BY END-USER
7.5.5.
COUNTRY ANALYSIS
7.5.5.1.
ISRAEL
7.5.5.2.
IRAN
7.5.5.3.
SAUDI ARABIA
7.5.5.4.
SOUTH AFRICA
8.
COMPETITIVE LANDSCAPE
8.1. SAMSUNG ELECTRONICS CO., LTD.
8.2. UNETIXS VASCULAR INC. (ACQUIRED BY OPTO CIRCUITS)
8.3. ATRICURE, INC.
8.4. ESAOTE S.P.A.
8.5. BOSTON SCIENTIFIC CORPORATION
8.6. GE HEALTHCARE, INC.
8.7. HITACHI MEDICAL CORPORATION
8.8. TOSHIBA MEDICAL SYSTEMS CORPORATION (ACQUIRED
BY CANON, INC.)
8.9. FUJIFILM HOLDINGS CORPORATION
8.10.
CHISON MEDICAL IMAGING CO., LTD.
8.11.
MINDRAY MEDICAL INTERNATIONAL LIMITED
8.12.
PHILIPS HEALTHCARE
8.13.
ABBOTT VASCULAR, INC.
8.14.
STRYKER CORPORATION
8.15.
ULTRASOUND TECHNOLOGIES, LTD.
9.
METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY
TABLE 1 GLOBAL
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 2 TYPES OF SURGERY AND
PRICE IN THE US
TABLE 3 GLOBAL
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 4 GLOBAL
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 5 GLOBAL
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 6 GLOBAL
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICES 2019-2027 ($
MILLION)
TABLE 11 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 13 THE UNITED STATES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 14 THE UNITED STATES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 15 THE UNITED STATES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 16 THE UNITED STATES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 17 CANADA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 18 CANADA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 19 CANADA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 20 CANADA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 22 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 23 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICES 2019-2027 ($ MILLION)
TABLE 24 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 25 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 26 GERMANY
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 27 GERMANY
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 28 GERMANY
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 29 GERMANY
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 30 THE UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 31 THE UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 32 THE UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 33 THE UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 34 FRANCE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 35 FRANCE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 36 FRANCE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 37 FRANCE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 38 RUSSIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 39 RUSSIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 40 RUSSIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 41 RUSSIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 42 BENELUX
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 43 BENELUX
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 44 BENELUX CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 45 BENELUX
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 46 ITALY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 47 ITALY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 48 ITALY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 49 ITALY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 50 REST OF EUROPE
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 51 REST OF EUROPE
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 52 REST OF EUROPE
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 53 REST OF EUROPE
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 54 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 55 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 56 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICES 2019-2027 ($
MILLION)
TABLE 57 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 58 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 59 JAPAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 60 JAPAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 61 JAPAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 62 JAPAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 63 CHINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 64 CHINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 65 CHINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 66 CHINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 67 SOUTH KOREA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 68 SOUTH KOREA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 69 SOUTH KOREA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 70 SOUTH KOREA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 71 INDIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 72 INDIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 73 INDIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 74 INDIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 75 AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($
MILLION)
TABLE 76 AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($
MILLION)
TABLE 77 AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($
MILLION)
TABLE 78 AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($
MILLION)
TABLE 79 REST OF ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 80 REST OF ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 81 REST OF ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 82 REST OF ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 83 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 84 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 85 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICES 2019-2027 ($
MILLION)
TABLE 86 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 87 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 88 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 89 MEXICO CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 90 MEXICO CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 91 MEXICO CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 92 MEXICO CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 93 BRAZIL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 94 BRAZIL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 95 BRAZIL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 96 BRAZIL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 97 ARGENTINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 98 ARGENTINA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 99 ARGENTINA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 100 ARGENTINA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 101 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPES 2019-2027 ($ MILLION)
TABLE 102 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGIES 2019-2027 ($ MILLION)
TABLE 103 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICES 2019-2027 ($
MILLION)
TABLE 104 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 105 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 106 IRAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 107 IRAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 108 IRAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 109 IRAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 110 SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TEST TYPE 2019-2027 ($ MILLION)
TABLE 111 SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 112 SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DISPLAY DEVICE 2019-2027 ($ MILLION)
TABLE 113 SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END-USER 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 2 REGULATORY OUTLOOKS
IN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET
FIGURE 3 RATE OF CARDIAC
DISEASES IN AMERICA 2017 (%)
FIGURE 4 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN TRANSTHORACIC ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN TRANSESOPHAGEAL ECHOCARDIOGRAM 2019-2027 ($
MILLION)
FIGURE 6 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN STRESS ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN OTHER ECHOCARDIOGRAM 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN 2D ULTRASOUND 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN 3D & 4D ULTRASOUND 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN DOPPLER IMAGING 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN COLOR DISPLAY 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN BLACK & WHITE DISPLAY 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN HOSPITAL & CARDIOLOGY CENTERS 2019-2027 ($
MILLION)
FIGURE 14 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN HOME & AMBULATORY CARE SETTINGS 2019-2027 ($
MILLION)
FIGURE 15 GLOBAL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET IN OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 17 THE UNITED STATES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 18 CANADA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 19 EUROPE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 20 GERMANY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 21 THE UNITED KINGDOM
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 22 FRANCE CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 23 RUSSIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 24 BENELUX CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 25 ITALY CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 26 REST OF EUROPE
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 27 ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 28 JAPAN CARDIOVASCULAR ULTRASOUND
SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 29 CHINA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 30 SOUTH KOREA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 31 INDIA CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 32 AUSTRALIA & NEW
ZEALAND CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 33 ASEAN COUNTRIES
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 34 REST OF ASIA-PACIFIC
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 35 LATIN AMERICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 36 MEXICO CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 37 BRAZIL CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 38 ARGENTINA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 39 MIDDLE EAST AND AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 40 ISRAEL CARDIOVASCULAR ULTRASOUND
SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 41 IRAN CARDIOVASCULAR
ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 42 SAUDI ARABIA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)
FIGURE 43 SOUTH AFRICA
CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027 ($ MILLION)